SBIO
Fund Stats as of 06/22/2018
Symbol SBIO
CUSIP 00162Q 593
ISIN US00162Q5936
Inception Date 12/30/2014
Dividends Paid Annual
Fund Type Exchange Traded Fund
Market Price $38.83
Last Trade Price $38.82
NAV $38.85
NAV Change $0.13
Total Net Assets $227,293,370
Total Market Value $227,456,038
Premium/Discount(%) -0.05%
Difference ($) $-0.02
Volume 25,322
Shares Outstanding 5,850,000
Expenses as of 03/31/2018
Management Fee0.50%
Other Expenses0.00%
Total Operating Expenses0.50%
Fund Resources
Summary Prospectus 
Statement of Additional Information 
Quarterly Fact Sheet 
Statutory Prospectus 
Resource Library  

Index Characteristics as of 3/31/2018, subject to change

Index Top Ten Holdings

Index Name % of Index
Beigene Ltd-Adr 5.31%
Galapagos Nv-Spon Adr 3.86%
Sarepta Therapeutics In 3.65%
Agios Pharmaceuticals I 3.47%
Taro Pharmaceutical In 3.02%
Fibrogen Inc 2.89%
Ligand Pharmaceuticals 2.66%
Loxo Oncology Inc 2.62%
Array Biopharma Inc 2.58%
Tesaro Inc 2.37%

PMBI Drug Development Pipeline

Pre-Clinical 363
Phase I 356
Phase II 488
Phase III 140
Regulatory Filing for Approval 44
Other 35

Index Profile

Index Description Value
Number of Companies 93
Company Size ($ Millions)
   Average $2,741
   Median $1,110
   Largest $8,999
   Smallest $69
Weight of Top 10 32.43%
Large cap (>$10bn) 0.0%
Mid cap ($2-10bn) 59.90%
Small cap (<$2bn) 40.10%